ARCHIVES

House Committee Seeks Information on ImClone Insider Stock Trading.

This article is from The Cancer Letter archive.

Vol. 28 No. 13 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998

ACS Courage award Goes To Polhill, Former Beirut Hostage

March 29, 1991

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

NCI 1985 Bypass Budget By Groups

May 20, 1983

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975